More on normal prothrombin times in the presence of therapeutic levels of rivaroxaban - Early experience from King's college hospital

British Journal of Haematology

Volumn 162, Issue 5, 2013, Pages 717-718

  Patel, Jignesh P ^a,b   Roberts, Lara N ^a   Chitongo, Paradzai B ^a   Patel, Raj K ^a   Arya, Roopen ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Direct Xa inhibitors; Prothrombin time; Rivaroxaban

Indexed keywords

RIVAROXABAN;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; HUMAN; LETTER; PRIORITY JOURNAL; PROTHROMBIN TIME; SCREENING TEST;

DIRECT-XA INHIBITORS; PROTHROMBIN TIME; RIVAROXABAN;

ANTICOAGULANTS; HUMANS; MORPHOLINES; THIOPHENES; VENOUS THROMBOSIS;

EID: 84881668875     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12423     Document Type: Letter

References (4)

1. Baglin, T., Keeling, D. & Kitchen, S. (2012) Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology. British Journal of Haematology, 159, 427-429.
2. Hillarp, A., Baghaei, F., Fagerberg, B.I., Gustafsson, K.M., Stigendal, L., Sten-Linder, M., Strandberg, K. & Lindahl, T.L. (2011) Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays. Journal of Thrombosis and Haemostasis, 9, 133-139.
3. Samama, M.M., Martinoli, J.L., LeFlem, L., Guinet, C., Plu-Bureau, G., Depasse, F. & Perzborn, E. (2010) Assessment of laboratory assays to measure rivaroxaban-an oral, direct factor Xa inhibitor. Thrombosis and Haemostasis, 103, 815-825.
4. van Veen, J.J., Smith, J., Kitchen, S. & Makris, M. (2013) Normal prothrombin time in the presence of therapeutic levels of rivaroxaban. British Journal of Haematology, 160, 859-861.